Table 2. Univariate and multivariate analyses for overall survival in patients with bladder cancer.
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| Hazard ratio | 95 % CI | p value | Hazard ratio | 95 % CI | p value | |
| Age (> 65y vs. ≤ 65y) | 1.27 | 0.69–2.35 | 0.44 | |||
| Gender (male vs. female) | 0.52 | 0.19–1.47 | 0.22 | |||
| Multifocality (multifocal vs. unifocal) | 1.28 | 0.69–2.38 | 0.42 | |||
| Tumor size (> 3 cm vs. ≤ 3 cm) | 0.73 | 0.39–1.36 | 0.32 | |||
| Stage (T2–4 vs. Ta-1) | 4.49 | 2.08–9.71 | < 0.001 | 5.21 | 1.78–15.31 | < 0.001 |
| Grade (high vs. low) | 3.74 | 1.87–7.87 | < 0.001 | 2.29 | 1.14–4.16 | 0.008 |
| Recurrence (yes vs.no) | 2.05 | 1.53–3.13 | 0.007 | 1.64 | 0.87–3.11 | 0.13 |
| Kindlin-2 expression (high vs. low) | 2.86 | 1.57–5.23 | < 0.001 | 1.73 | 1.22–2.43 | 0.026 |
| Stromal fibroblasts number (high vs. low) | 1.22 | 0.93–1.59 | 0.18 | |||
Abbreviations: CI: confidence interval.